153 related articles for article (PubMed ID: 35850446)
21. The active fraction of Garcinia yunnanensis suppresses the progression of colorectal carcinoma by interfering with tumorassociated macrophage-associated M2 macrophage polarization in vivo and in vitro.
Sui H; Tan H; Fu J; Song Q; Jia R; Han L; Lv Y; Zhang H; Zheng D; Dong L; Wang S; Li Q; Xu H
FASEB J; 2020 Jun; 34(6):7387-7403. PubMed ID: 32283574
[TBL] [Abstract][Full Text] [Related]
22. Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway.
Lin W; Zheng L; Zhuang Q; Zhao J; Cao Z; Zeng J; Lin S; Xu W; Peng J
BMC Complement Altern Med; 2013 Jun; 13():144. PubMed ID: 23800091
[TBL] [Abstract][Full Text] [Related]
23. Leukocyte populations and IL-6 in the tumor microenvironment of an orthotopic colorectal cancer model.
Miller S; Senior PV; Prakash M; Apostolopoulos V; Sakkal S; Nurgali K
Acta Biochim Biophys Sin (Shanghai); 2016 Apr; 48(4):334-41. PubMed ID: 26893144
[TBL] [Abstract][Full Text] [Related]
24. Modeling Colorectal Cancer Progression Through Orthotopic Implantation of Organoids.
de Sousa E Melo F; Harnoss JM; Kljavin N; Scott R; Sohn C; Leong KG; de Sauvage FJ
Methods Mol Biol; 2020; 2171():331-346. PubMed ID: 32705654
[TBL] [Abstract][Full Text] [Related]
25. Development of a colon cancer GEMM-derived orthotopic transplant model for drug discovery and validation.
Martin ES; Belmont PJ; Sinnamon MJ; Richard LG; Yuan J; Coffee EM; Roper J; Lee L; Heidari P; Lunt SY; Goel G; Ji X; Xie Z; Xie T; Lamb J; Weinrich SL; VanArsdale T; Bronson RT; Xavier RJ; Vander Heiden MG; Kan JL; Mahmood U; Hung KE
Clin Cancer Res; 2013 Jun; 19(11):2929-40. PubMed ID: 23403635
[TBL] [Abstract][Full Text] [Related]
26. IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.
Zhang Y; Davis C; Shah S; Hughes D; Ryan JC; Altomare D; Peña MM
Mol Carcinog; 2017 Jan; 56(1):272-287. PubMed ID: 27120577
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of anti-RON antibody Zt/g4-drug maytansinoid conjugation (Anti-RON ADC) as a novel therapeutics for targeted colorectal cancer therapy.
Feng L; Yao HP; Wang W; Zhou YQ; Zhou J; Zhang R; Wang MH
Clin Cancer Res; 2014 Dec; 20(23):6045-58. PubMed ID: 25294907
[TBL] [Abstract][Full Text] [Related]
28. Multipotent mesenchymal stromal cells promote tumor growth in distinct colorectal cancer cells by a β1-integrin-dependent mechanism.
Widder M; Lützkendorf J; Caysa H; Unverzagt S; Wickenhauser C; Benndorf RA; Schmoll HJ; Müller-Tidow C; Müller T; Müller LP
Int J Cancer; 2016 Feb; 138(4):964-75. PubMed ID: 26356035
[TBL] [Abstract][Full Text] [Related]
29. Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide.
Novoa Díaz MB; Carriere P; Gigola G; Zwenger AO; Calvo N; Gentili C
World J Gastroenterol; 2022 Jul; 28(26):3177-3200. PubMed ID: 36051345
[TBL] [Abstract][Full Text] [Related]
30. Small-molecule activating SIRT6 elicits therapeutic effects and synergistically promotes anti-tumor activity of vitamin D
Shang J; Zhu Z; Chen Y; Song J; Huang Y; Song K; Zhong J; Xu X; Wei J; Wang C; Cui L; Liu CY; Zhang J
Theranostics; 2020; 10(13):5845-5864. PubMed ID: 32483423
[TBL] [Abstract][Full Text] [Related]
31. Tumor models to assess immune response and tumor-microbiome interactions in colorectal cancer.
Yuan C; Zhao X; Wangmo D; Alshareef D; Gates TJ; Subramanian S
Pharmacol Ther; 2022 Mar; 231():107981. PubMed ID: 34480964
[TBL] [Abstract][Full Text] [Related]
32. A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries.
Veeranki OL; Tong Z; Mejia A; Verma A; Katkhuda R; Bassett R; Kim TB; Wang J; Lang W; Mino B; Solis L; Kingsley C; Norton W; Tailor R; Wu JY; Krishnan S; Lin SH; Blum M; Hofstetter W; Ajani J; Kopetz S; Maru D
Dis Model Mech; 2019 Dec; 12(12):. PubMed ID: 31732509
[TBL] [Abstract][Full Text] [Related]
33. Characterization of an Orthotopic Colorectal Cancer Mouse Model and Its Feasibility for Accurate Quantification in Positron Emission Tomography.
Rapic S; Vangestel C; Verhaeghe J; Van den Wyngaert T; Hinz R; Verhoye M; Pauwels P; Staelens S; Stroobants S
Mol Imaging Biol; 2017 Oct; 19(5):762-771. PubMed ID: 28194632
[TBL] [Abstract][Full Text] [Related]
34. Endoscopy-guided orthotopic implantation of colorectal cancer cells results in metastatic colorectal cancer in mice.
Bettenworth D; Mücke MM; Schwegmann K; Faust A; Poremba C; Schäfers M; Domagk D; Lenz P
Clin Exp Metastasis; 2016 Aug; 33(6):551-62. PubMed ID: 27146063
[TBL] [Abstract][Full Text] [Related]
35. The Diet as a Modulator of Tumor Microenvironment in Colorectal Cancer Patients.
Collado M; Castillo M; Muñoz de Mier GJ; de la Pinta C; Peña C
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108477
[TBL] [Abstract][Full Text] [Related]
36. In vivo analysis of insulin-like growth factor type 1 receptor humanized monoclonal antibody MK-0646 and small molecule kinase inhibitor OSI-906 in colorectal cancer.
Leiphrakpam PD; Agarwal E; Mathiesen M; Haferbier KL; Brattain MG; Chowdhury S
Oncol Rep; 2014 Jan; 31(1):87-94. PubMed ID: 24173770
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of Chanling Gao on the proliferation and liver metastasis of transplanted colorectal cancer in nude mice.
Yang B; Pan CS; Li Q; Yang Z; Long FX; Fan JY; Wang CS; Han JY; Tang DX
PLoS One; 2019; 14(2):e0201504. PubMed ID: 30789971
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of innate and adaptive immunity in colorectal cancer.
Grizzi F; Bianchi P; Malesci A; Laghi L
World J Gastroenterol; 2013 Jan; 19(2):174-84. PubMed ID: 23345940
[TBL] [Abstract][Full Text] [Related]
39. Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma.
Kobayashi H; Gieniec KA; Ng JQ; Goyne J; Lannagan TRM; Thomas EM; Radford G; Wang T; Suzuki N; Ichinose M; Wright JA; Vrbanac L; Burt AD; Takahashi M; Enomoto A; Worthley DL; Woods SL
J Vis Exp; 2021 Sep; (175):. PubMed ID: 34542536
[TBL] [Abstract][Full Text] [Related]
40. Anti-tumor effects of ONC201 in combination with VEGF-inhibitors significantly impacts colorectal cancer growth and survival in vivo through complementary non-overlapping mechanisms.
Wagner J; Kline CL; Zhou L; Khazak V; El-Deiry WS
J Exp Clin Cancer Res; 2018 Jan; 37(1):11. PubMed ID: 29357916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
